We anticipate trends and changes in competitive dynamics within industries, and proactively advise our clients on how to exploit these factors. In addition, we are highly experienced in meeting our clients’ objectives by creating unique transaction structures to bridge buyer and seller concerns.
We have strong relationships with virtually all of the leading companies and investors within the industries in which we focus. Our broad network of relationships enables us to provide our clients with an informed perspective on industry and market trends, as well as thoughtful strategic ideas.
We substantiate our advice and theses through our rigorous analytical approach. Our analyses are anchored on macro, industry, and situation specific examinations. The advice we offer to clients incorporates a focus on value creation from both a company and shareholder perspective.
We have extensive transaction experience and have worked on major, industry shaping transactions. Over the last decade, our senior bankers have advised on trillions of dollars in announced transactions.
We have assembled a team of highly skilled, experienced and trusted advisors. We offer differentiated advice and add strategic value for our clients in both their executive suites and board rooms. We help clients maintain focus in high stakes situations and are willing to tell a client to walk away from a deal if we believe that is the best answer.
Financial advisor to DXC Technology in connection with its acquisition of Luxoft
Value: $2 billion
Financial advisor to Pfizer in connection with its newly formed consumer healthcare JV with GlaxoSmithKline
Value: 32% Stake (combined revenue of ~$13 billion)
Exclusive advisor in connection with the acquisition of the Italian CHP portfolio of Enel X and the formation of a joint venture for further investment in the sector with Enel X
All Recent Transactions